In a surprising move, Australia’s Therapeutic Goods Administration (TGA) has announced that it will permit the prescribing of MDMA and Psilocybin from July this year. The change comes via a rescheduling of medicines containing the drugs from Schedule 9 (‘Prohibited Substance’) to Schedule 8 (‘Controlled Drug’). Importantly, prescriptions may only be written by certain psychiatrists…

Source

Previous articlePanel: Psychedelic Research Methods
Next articleRevive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch